Perrigo
Perrigo Company
The Perrigo Company is a prominent American-Irish pharmaceutical company that specializes in the production of over-the-counter (OTC) health and wellness products. Founded in 1887, Perrigo has grown to become one of the largest manufacturers of OTC products in the world, with a significant presence in both the United States and Europe.
History
Perrigo was established in 1887 by Luther Perrigo in Allegan, Michigan. Initially, the company focused on the packaging and distribution of patent medicines. Over the years, Perrigo expanded its operations and product lines, eventually becoming a leading supplier of store-brand OTC medications.
In the 1990s, Perrigo began to expand internationally, acquiring several companies in Europe and other regions. This expansion helped Perrigo to diversify its product offerings and increase its global market share.
Operations
Perrigo operates in several key areas, including the production of OTC medications, nutritional supplements, and personal care products. The company is known for its ability to produce high-quality, affordable alternatives to brand-name pharmaceuticals.
Perrigo's manufacturing facilities are located in various countries, allowing the company to efficiently serve its global customer base. The company's commitment to quality and innovation has earned it a strong reputation in the pharmaceutical industry.
Products
Perrigo's product portfolio includes a wide range of OTC medications, such as pain relievers, cough and cold remedies, gastrointestinal treatments, and allergy medications. In addition to OTC products, Perrigo also produces prescription pharmaceuticals and active pharmaceutical ingredients (APIs).
Corporate Structure
Perrigo is headquartered in Dublin, Ireland, with significant operations in the United States. The company's corporate structure is designed to support its global operations and facilitate efficient decision-making across its various business units.
Acquisitions and Partnerships
Throughout its history, Perrigo has pursued a strategy of growth through acquisitions and strategic partnerships. This approach has enabled the company to expand its product offerings and enter new markets. Notable acquisitions include the purchase of Omega Pharma in 2015, which significantly increased Perrigo's presence in the European market.
Challenges and Controversies
Like many large pharmaceutical companies, Perrigo has faced challenges related to regulatory compliance, competition, and market dynamics. The company has also been involved in legal disputes concerning patent rights and product liability.
Future Outlook
Perrigo continues to focus on expanding its product lines and increasing its market share in the global OTC pharmaceutical industry. The company is committed to innovation and aims to develop new products that meet the evolving needs of consumers.
Related pages
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
